CoChat

Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The aim of this meta-analysis was to determine the efficacy and safety of glyburide as a treatment for gestational diabetes mellitus (GDM) compared to insulin. METHODS: A meta-analysis was conducted to compare the management of gestational diabetes with glyburide and insulin. Studies fulfilling all of the following inclusion criteria were included in this meta-analysis: subjects were women with gestational diabetes requiring drug treatment; the comparison treatment included glyburide vs insulin; one or more outcomes (maternal or neonatal) should be provided in the individual study; the study design should be a randomized control trial. Exclusion criteria: non-RCT studies; non-human data. PubMed, Embase and CENTRAL databases were searched from inception until 10 October 2016. RESULTS: Ten randomized control trials involving 1194 participants met the inclusion criteria and were included. 13 primary outcomes (6 maternal, 7 neonatal) and 26 secondary outcomes (9 maternal, 17 neonatal) were detected and analyzed in this study. Glyburide significantly increased the risk of any neonatal hypoglycemia [risk ratio (RR), 1.89; 95% confidence interval (95%CI), 1.26 to 2.82; p = 0.002]. Sensitivity analysis confirmed robustness of this result [RR, 2.29; 95%CI, 1.49 to 3.54; p = 0.0002]. No differences were observed between the two groups with respect to birth weights [mean difference (MD), 79; 95%CI, -64 to 221.99; p = 0.28] and the risk of macrosomia [RR, 1.69; 95%CI, 0.57 to 5.08; p = 0.35]. CONCLUSION: For women with gestational diabetes, no differences in maternal short term outcomes were observed in those treated with glyburide or insulin. However, the incidence of neonatal hypoglycemia was higher in the glyburide group compared to the insulin group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0182488

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Study selection flowchart.
Fig 1 Study selection flowchart.CC BY · PubMed Central
Fig 2 Risk of bias of studies comparing glyburide and insulin.
Fig 2 Risk of bias of studies comparing glyburide and insulin.CC BY · PubMed Central
Fig 3 Risk of bias summary of studies comparing glyburide and insulin.
Fig 3 Risk of bias summary of studies comparing glyburide and insulin.CC BY · PubMed Central
Fig 4 Maternal outcomes comparing glyburide and insulin.
Fig 4 Maternal outcomes comparing glyburide and insulin.CC BY · PubMed Central
Fig 5 Neonatal outcomes comparing glyburide and insulin.
Fig 5 Neonatal outcomes comparing glyburide and insulin.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 73

Metadata

Authors
Song, R., Chen, L., Chen, Y., Si, X., Liu, Y., Liu, Y., Irwin, D. M., & Feng, W.
Affiliations
  • Peking University People's Hospital (CN)
  • University of Toronto (CA)
Corresponding author
  • Irwin, David M.
  • Feng, Wanyu
Venue
PLOS ONE
Published
2017-08-03
Volume
12
Issue
8
Pages
e0182488
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2744038916
Cited by
73
References
43
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 29 · 2020: 11 · 2019: 5 · 2018: 10 · 2017: 2
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
gestational diabetes mellitus, glibenclamide, insulin therapy, neonatal hypoglycemia, macrosomia, birth weight, maternal outcomes, neonatal outcomes, antidiabetic drug comparison
MeSH terms
Adult, Birth Weight, Female, Glyburide, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Infant, Newborn, Diseases, Insulin, Pregnancy, Research Design, Incidence, Randomized Controlled Trials as Topic, Diabetes, Gestational, Treatment Outcome, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0182488
The paper
Song, R., Chen, L., Chen, Y., Si, X., Liu, Y., Liu, Y., Irwin, D. M., & Feng, W. (2017). Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0182488

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.